Genocea Biosciences, Inc. (OTCPK: GNCA.Q)
Health Care · Biotechnology · US
$0.00
— today · 0.0% 1Y
Genocea Biosciences, Inc. (OTCPK: GNCA.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $59.00.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.01.
Tweenvest scores Genocea Biosciences, Inc. across four factors: quality 35/100, value 45/100. Its strongest factor is value.
GNCA.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $59.00
- Revenue (TTM)
- $1.91M
- P/E
- —
- EPS
- -0.53
- Dividend yield
- —
- Beta (5Y)
- 37.98
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 58.78M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Infinity Pharmaceuticals, Inc.OTCPK: INFI.Q | $91.00 | $0.00 | -99.00% |
| RenovaCare, Inc.OTCPK: RCAR | $87.00 | $— | — |
| Gelesis Holdings, Inc.OTCPK: GLSH.Q | $73.00 | $— | — |
| Athersys, Inc.OTCPK: ATHX.Q | $62.00 | $0.00 | -90.00% |
| Mymetics CorporationOTCPK: MYMX | $46.00 | $— | — |
| HAVN Life Sciences Inc.OTCPK: HAVL.F | $29.00 | $— | — |
| TetraLogic Pharmaceuticals CorporationOTCPK: TLOG | $24.00 | $0.00 | — |
| IMV Inc.OTCPK: IMVI.F | $15.00 | $0.00 | — |
Figures last refreshed Oct 18, 2026.